These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19759093)

  • 41. White-matter microstructure in previously drug-naive patients with schizophrenia after 6 weeks of treatment.
    Wang Q; Cheung C; Deng W; Li M; Huang C; Ma X; Wang Y; Jiang L; Sham PC; Collier DA; Gong Q; Chua SE; McAlonan GM; Li T
    Psychol Med; 2013 Nov; 43(11):2301-9. PubMed ID: 23442742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease.
    Zhao C; Zhu J; Liu X; Pu C; Lai Y; Chen L; Yu X; Hong N
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():27-32. PubMed ID: 29292241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormalities of regional homogeneity and its correlation with clinical symptoms in Naïve patients with first-episode schizophrenia.
    Zhao X; Yao J; Lv Y; Zhang X; Han C; Chen L; Ren F; Jin Z; Li Y; Sui Y
    Brain Imaging Behav; 2019 Apr; 13(2):503-513. PubMed ID: 29736883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporolimbic volume reductions in schizophrenia.
    Gur RE; Turetsky BI; Cowell PE; Finkelman C; Maany V; Grossman RI; Arnold SE; Bilker WB; Gur RC
    Arch Gen Psychiatry; 2000 Aug; 57(8):769-75. PubMed ID: 10920465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI.
    Suzuki M; Nohara S; Hagino H; Kurokawa K; Yotsutsuji T; Kawasaki Y; Takahashi T; Matsui M; Watanabe N; Seto H; Kurachi M
    Schizophr Res; 2002 May; 55(1-2):41-54. PubMed ID: 11955962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.
    Takahashi T; Wood SJ; Yung AR; Soulsby B; McGorry PD; Suzuki M; Kawasaki Y; Phillips LJ; Velakoulis D; Pantelis C
    Arch Gen Psychiatry; 2009 Apr; 66(4):366-76. PubMed ID: 19349306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
    Ebdrup BH; Raghava JM; Nielsen MØ; Rostrup E; Glenthøj B
    J Psychiatry Neurosci; 2016 Mar; 41(2):133-41. PubMed ID: 26599135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Brain morphometry of individuals with schizophrenia with and without antipsychotic medication – The Northern Finland Birth Cohort 1966 Study.
    Moilanen J; Huhtaniska S; Haapea M; Jääskeläinen E; Veijola J; Isohanni M; Koponen H; Miettunen J
    Eur Psychiatry; 2015 Jul; 30(5):598-605. PubMed ID: 25791180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MTR abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.
    Bohner G; Milakara D; Witthaus H; Gallinat J; Scheel M; Juckel G; Klingebiel R
    Schizophr Res; 2012 May; 137(1-3):85-90. PubMed ID: 22377101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms.
    Sanfilipo M; Lafargue T; Rusinek H; Arena L; Loneragan C; Lautin A; Feiner D; Rotrosen J; Wolkin A
    Arch Gen Psychiatry; 2000 May; 57(5):471-80. PubMed ID: 10807487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Features of structural brain abnormality detected in first-episode psychosis.
    Fannon D; Chitnis X; Doku V; Tennakoon L; O'Ceallaigh S; Soni W; Sumich A; Lowe J; Santamaria M; Sharma T
    Am J Psychiatry; 2000 Nov; 157(11):1829-34. PubMed ID: 11058481
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased white matter FA values in the left inferior frontal gyrus is a possible intermediate phenotype of schizophrenia: evidences from a novel group strategy.
    Ou J; Lyu H; Hu M; Li J; Guo W; Guo X; Li L; Zheng J; Wei Q; Liu F; He Z; Wang J; Liu F; Wu R; Chen J; Li L; Hu B; Chen H; Zhao J
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):89-98. PubMed ID: 27942861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Positive symptoms and white matter microstructure in never-medicated first episode schizophrenia.
    Cheung V; Chiu CP; Law CW; Cheung C; Hui CL; Chan KK; Sham PC; Deng MY; Tai KS; Khong PL; McAlonan GM; Chua SE; Chen E
    Psychol Med; 2011 Aug; 41(8):1709-19. PubMed ID: 20809999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study.
    Bartzokis G; Nuechterlein KH; Lu PH; Gitlin M; Rogers S; Mintz J
    Biol Psychiatry; 2003 Mar; 53(5):412-21. PubMed ID: 12614994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment.
    McClure RK; Carew K; Greeter S; Maushauer E; Steen G; Weinberger DR
    Schizophr Res; 2008 Jan; 98(1-3):29-39. PubMed ID: 17976957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum.
    Staal WG; Hulshoff Pol HE; Schnack HG; van Haren NE; Seifert N; Kahn RS
    Am J Psychiatry; 2001 Jul; 158(7):1140-2. PubMed ID: 11431237
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal white matter connections between medial frontal regions predict symptoms in patients with first episode schizophrenia.
    Ohtani T; Bouix S; Lyall AE; Hosokawa T; Saito Y; Melonakos E; Westin CF; Seidman LJ; Goldstein J; Mesholam-Gately R; Petryshen T; Wojcik J; Kubicki M
    Cortex; 2015 Oct; 71():264-76. PubMed ID: 26277547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural brain changes in First Episode Schizophrenia compared with Fronto-Temporal Lobar Degeneration: a meta-analysis.
    Olabi B; Ellison-Wright I; Bullmore E; Lawrie SM
    BMC Psychiatry; 2012 Aug; 12():104. PubMed ID: 22870896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.
    Witthaus H; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Gallinat J; Ruhrmann S; Brüne M; Heinz A; Klingebiel R; Juckel G
    Psychiatry Res; 2009 Sep; 173(3):163-9. PubMed ID: 19616415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.